Checkpoint Inhibitors and Rheumatic Disease

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

Checkpoint Inhibitors and Rheumatic Disease

By NYU Langone FEATURING Anne Bass

796 views

April 16, 2024

Comments 0

Systemic Sclerosis-Associated Interstitial Lung Disease: A Patient&#…

Feat. E. Volkmann

Barriers in Diagnosing Fibrosing Interstitial Lung Diseases (ILDs)

Feat. M. Zlupko

Dermatology-Rheumatology Grand Rounds: The Whole Is Greater Than the…

University of Colorado Department of Medicine

E. Wallace, J. Zell

663 views

3 years ago

What to Do When Patch Testing is Negative?

American Contact Dermatitis Society (ACDS)

M. Montanez-Wiscovich

772 views

9 months ago

Checkpoint Inhibitors, Arthritis and Other Autoimmune Triggers

West Virginia State Rheumatology Society

J. Bustamante

413 views

4 months ago

Update on the New ANA Classification System

Keck School of Medicine of USC

E. Taylor-Albert

801 views

1 year ago

Imaging Considerations for the Dermatologist

Masterclasses in Dermatology

C. Bakewell

706 views

11 months ago

Skin Rash Diagnosis: Inflammatory Skin Biopsy Approaches, Reaction P…

Jerad Gardner

615 views

2 years ago

COVID-19 and the Risk of Autoimmune Disease, Including Alopecia Area…

Evidence-Based Hair

J. Donovan

102 views

11 months ago

EADV 2023 Insights: Infectious Granulomatous Skin Diseases

EADV 2023 Insights

E. Laffitte

253 views

1 year ago

Outcomes of COVID-19 Infection in Patients With Primary Systemic Vas…

ACR Convergence 2021 Coverage

S. Sattui Cortes

153 views

3 years ago

EGPA: Look Carefully at the Heart

Cleveland Clinic Rheumatology

W. Tang

49 views

5 years ago

Could EGPA be Treated with Biologics?

Cleveland Clinic Rheumatology

M. Wechsler

125 views

5 years ago

New and Emerging Treatments in Cutaneous Vasculitis

Cleveland Clinic Rheumatology

C. Langford

428 views

5 years ago

Immunomodulatory Drugs (IMIDs) Advances in Disease Pathogenesis

Cleveland Clinic Rheumatology

W. Rigby

63 views

5 years ago

EGPA: Challenges and Prognosis

Cleveland Clinic Rheumatology

R. Hajj-Ali

199 views

5 years ago

Case: Challenges in Clinical Immunology

Cleveland Clinic Rheumatology

L. Calabrese

42 views

5 years ago

Why Personal Behavior Affects Immune Mediated Inflammatory Diseases

Cleveland Clinic Rheumatology

L. Calabrese

227 views

5 years ago

74 y/o Female With Dermatomyositis and Calcinosis Cutis

Cleveland Clinic Rheumatology

A. Fernandez

247 views

5 years ago

Pulmonary Arterial Hypertension in Rheumatic Disease: Diagnosis and …

Scripps Health: 2019 Third Annual Clinical Advances in the Diagnosis and Management of Pulmonary Hypertension

R. Keating

593 views

5 years ago

Pulmonary Evaluation of Sarcoidosis

10th Annual California Heart Rhythm Symposium

757 views

5 years ago

Rheumatologic Evaluation and Treatment of Cardiac Sarcoidosis

10th Annual California Heart Rhythm Symposium

35 views

5 years ago

AUTOPLAY

Login

Login

Join VuMedi

Checkpoint Inhibitors and Rheumatic Disease

Systemic Sclerosis-Associated Interstitial Lung Disease: A Patient&#…

Barriers in Diagnosing Fibrosing Interstitial Lung Diseases (ILDs)

Recommended

Dermatology-Rheumatology Grand Rounds: The Whole Is Greater Than the…

What to Do When Patch Testing is Negative?

Checkpoint Inhibitors, Arthritis and Other Autoimmune Triggers

Update on the New ANA Classification System

Imaging Considerations for the Dermatologist

Skin Rash Diagnosis: Inflammatory Skin Biopsy Approaches, Reaction P…

COVID-19 and the Risk of Autoimmune Disease, Including Alopecia Area…

EADV 2023 Insights: Infectious Granulomatous Skin Diseases

Outcomes of COVID-19 Infection in Patients With Primary Systemic Vas…

EGPA: Look Carefully at the Heart

Could EGPA be Treated with Biologics?

New and Emerging Treatments in Cutaneous Vasculitis

Immunomodulatory Drugs (IMIDs) Advances in Disease Pathogenesis

EGPA: Challenges and Prognosis

Case: Challenges in Clinical Immunology

Why Personal Behavior Affects Immune Mediated Inflammatory Diseases

74 y/o Female With Dermatomyositis and Calcinosis Cutis

Pulmonary Arterial Hypertension in Rheumatic Disease: Diagnosis and …

Pulmonary Evaluation of Sarcoidosis

Rheumatologic Evaluation and Treatment of Cardiac Sarcoidosis